Inflammatory/anti-inflammatory mechanisms in the brain following exposure to stress;Mecanismos inflamatorios/antiinflamatorios en el cerebro tras la exposición a estrés

Revista de Neurologia

Volumn 46, Issue 11, 2008, Pages 675-683

  Garcia Bueno B ^a   Leza, Juan C ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

15d PGJ2; Catecholamines; Cytosines; Glucocorticoids; Glutamate; Neuroinflammation; PPAR gamma; Stress

Indexed keywords

CYTOSINE DERIVATIVE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE; STRESS HORMONE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; HUMAN; INFLAMMATION; NEUROLOGIC DISEASE; STRESS;

EID: 45249083893     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4611.2008073     Document Type: Article

References (85)

1. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5: 575-81.
2. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids -new mechanisms for old drugs. N Engl J Med 2005; 353: 1711-23.
3. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 138: 32.
4. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 1993; 60: 1650-7.
5. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147 (Suppl 1): S232-40.
6. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290-303.
7. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 2002; 16: 622-53.
8. Klotz L, Sastre M, Kreutz A, Gavrilyuk V, Klockgether T, Feinstein DL, et al. Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons. J Neurochem 2003; 86: 907-16.
9. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2006; 21: 259-272.
10. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000; 18: 309-45.
11. McKay LI, Cidlowski JA. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 2000; 14: 1222-34.
12. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996; 1: 1-19.
13. Stein-Behrens BA, Lin WJ, Sapolsky RM. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J Neurochem 1994 63: 596-602.
14. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, De Sá-Lima L, Avellar MC, et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 2006; 26: 3813-20.
15. Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 2003; 84: 705-16.
16. MacPherson A, Dinkel K, Sapolsky RM. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp Neurol 2005; 194: 376-83.
17. Uz T, Dwivedi Y, Savani PD, Impagnatiello F, Pandey G, Manev H. Glucocorticoids stimulate inflammatory 5-lipoxygenase gene expression and protein translocation in the brain. J Neurochem 1999; 73: 693-9.
18. Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol 2006; 171: 72-85.
19. De Pablos RM, Villarán RF, Argüelles S, Herrera AJ, Venero JL, Ayala A, et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 2006; 26: 5709-19.
20. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats possible involvement of prostaglandin. Endocrinology 1988; 122: 1773-9.
21. Kronfol Z, Remick DG. Cytokines and the brain implications for clinical psychiatry. Am J Psychiatry 2000; 157: 683-94.
22. Kim YK, Maes M. The role of the cytokine network in psychological stress. Acta Neuropsychiatrica 2003; 15: 148-55.
23. Agarwal SK, Marshall GD Jr. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress- related immune dysfunction. J Interferon Cytokine Res 1998; 18: 1059-68.
24. Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160: 1554-65.
25. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999; 461: 117-27.
26. Wiegers GJ, Reul JM. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol Sci 1998; 19: 317-21.
27. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002; 67: 161-72.
28. Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, et al. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002; 26: 155-63.
29. Hurtado O, Cárdenas A, Lizasoain I, Boscá L, Leza JC, Lorenzo P, et al. Up-regulation of TNFa convertase (TACE/ADAM17) after oxygen-glucose deprivation in rat forebrain slices. Neuropharmacology 2001; 40: 1094-102.
30. Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-25.
31. Nguyen KT, Deak T, Owens SM, Kohno T, Fleshner M, Watkins LR, et al. Exposure to acute stress induces brain interleukin-1beta protein in the rat. J Neurosci 1998; 18: 2239-46.
32. Minami M, Guraishi Y, Yamaguchi T, Nakai S, Hirai Y, Satoh M. Immobilization stress induces interleukin-1? mRNA in the rat hypothalamus. Neurosci Lett 1991; 123: 254-6.
33. Maier SF, Watkins LR. Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998; 105: 83-107.
34. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005; 135: 1295-307.
35. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice. J Exp Med 1996; 183: 311-6.
36. Takaki A, Huang QH, Somogyvari-Vigh A, Arimura A. Immobilization stress may increase plasma interleukin 6 via central and peripheral catecholamines. Neuroimmunomodulation 1994; 1: 335-42.
37. Kitamura H, Konno A, Morimatsu M, Jung BD, Kimura K, Saito M. Immobilization stress increases hepatic IL-6 expression in mice. Biochem Biophys Res Commun 1997; 238: 707-11.
38. Oka T, Oka K, Hori T. Mechanisms and mediators of psychological stress-induced rise in core temperature. Psychosom Med 2001; 63: 476-86.
39. Baldwin AS Jr. The NF-kappa B and I kappa-B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-83.
40. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Boscá L, et al. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem 2001; 76: 532-8.
41. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003; 100: 1920-5.
42. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
43. Gross SS, Wolin MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995; 57: 737-69.
44. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-8.
45. Leza JC, Salas E, Sawicki G, Russell JC, Radomski MW. The effect of stress on homeostasis in JCR:LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther 1998; 286: 1397-403.
46. Calza L, Giardino L, Ceccatelli S. NOS mRNA in the paraventricular nucleus of young and old rats after immobilization stress. Neuroreport 1993; 4: 627-30.
47. Milakofsky L, Harris N, Vogel WH. Effects of repeated stress on plasma arginine levels in young and old rats. Physiol Behav 1993; 54: 725-8.
48. Olivenza, R, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, et al. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem 2000; 74: 785-91.
49. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress-induced increase in extracellular sucrose space in rats is mediated by nitric oxide. Brain Res 2002; 938: 87-91.
50. Madrigal JL, Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Rodrigo P, et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001; 24: 420-29.
51. Miettinen S, Fusco FR, Yrjanheikki J, Keinanen R, Hirvonen T, Roivainen R, et al. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci U S A 1997; 94: 6500-5.
52. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-55.
53. Pasinetti GM. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J Neurosci Res 1998; 54: 1-6.
54. Araki E, Forster C, Dubinsky JM, Ross ME, Iadecola C. Cyclooxyge nase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity. Stroke 2001; 32: 2370-5.
55. Takadera T, Yumoto H, Tozuka Y, Ohyashiki T. Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells. Neurosci Lett 2002; 317: 61-4.
56. Egan RW, Paxton J, Kuehl FA Jr. Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 1976; 251: 7329-35.
57. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurones: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-86.
58. Katafuchi T, Takaki A, Take S, Kondo T, Yoshimura M. Endotoxin inhibitor blocks heat exposure-induced expression of brain cytokine mRNA in aged rats. Brain Res Mol Brain Res 2003; 118: 24-32.
59. Nie SN, Sun HC, Wu XH, Qian XM. Cyclooxygenase 2, pS2, inducible nitric oxid-e synthase and transforming growth factor alpha in gastric adaptation to stress. World J Gastroenterol 2004; 10: 3537-41.
60. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, et al. Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 2003; 28: 1579-88.
61. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
62. Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, et al. Impaired adrenal stress response in toll-like receptor 2-deficient mice. Proc Natl Acad Sci U S A 2004; 101: 16695-700.
63. Zacharowski K, Zacharowski PA, Koch A, Baban A, Tran N, Berkels R, et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci U S A 2006; 103: 6392-7.
64. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171-9.
65. Feinstein DL. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther 2003; 5: 67-73.
66. Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest Anim Endocrinol 2002; 22: 1-23.
67. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A 1997; 94: 4312-7.
68. Kainu T, Wikstrom AC, Gustafsson JA, Pelto-Huikko M. Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 1994; 5: 2481-5.
69. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martínez A, Pérez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator- activated receptor gamma activation. J Biol Chem 2005; 280: 21453-62.
70. García-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 2005; 57: 885-94.
71. García-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/ nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl) 2005; 180: 513-22.
72. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
73. Heneka MT, Feinstein DL, Galea E, Gleichmann M, Wullner U, Klockgether T. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine induced apoptotic cell death by inhibition of inducible nitric oxide synthase. J Neuroimmunol 1999; 100: 156-68.
74. García-Bueno B, Caso JR, Pérez-Nievas BG, Lorenzo P, Leza JC. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 2007; 32: 1251-60.
75. Castrillo A, Díaz-Guerra MJ, Hortelano S, Martín-Sanz P, Boscá L. Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxydelta(12,14)-prostaglandin J(2) in activated murine macrophages. Mol Cell Biol 2000; 20: 1692-8.
76. Niino M, Iwabuchi K, Kikuchi S, Ato M, Morohashi T, Ogata A, et al. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. J Neuroimmunol 2001; 116: 40-8.
77. Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J Neurochem 2002; 82: 615-24.
78. Sundararajan S, Gamboa JL, Victor NA, Wanderi EW, Lust WD, Landreth GE. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005; 130: 685-96.
79. Pereira MP, Hurtado O, Cárdenas A, Boscá L, Castillo J, Dávalos A, et al. Rosiglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J Cereb Blood Flow Metab 2006; 26: 218-29.
80. Blanco M, Moro MA, Dávalos A, Leira R, Castellanos M, Serena J, et al. Increased plasma levels of 15-deoxydelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke 2005; 36: 1189-94.
81. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci 2000; 20: 558-67.
82. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 2005; 128
83. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 2005; 128: 1442-53.
84. Pershadsingh HA, Heneka MT, Saini R, Amin NM, Broeske DJ, Feinstein DL. Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J Neuroinflammation 2004; 1: 3.
85. Galea E, Heneka MT, Dello Russo C, Feinstein DL. Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol 2003; 23: 625-35.